Global qPCR and dPCR Market Forecast up to 2025

Global qPCR and dPCR Market 2019–2025
 
 [93 pages report] This market research report includes a detailed segmentation of the global qPCR and dPCR market – By Technology Type (qPCR and dPCR), By Product Type (Instruments, Reagents & Consumables, and Software & Services), By Application (Clinical Diagnostics, Biomedical Research, and Others), By End Users (Hospitals & Laboratories, Pharmaceutical Companies, Academics, and Others), By Region (North America, Europe, Asia Pacific, and Rest of the World).
 
 Overview of the Global qPCR and dPCR Market Research
 Infoholic’s market research report predicts that the global qPCR and dPCR market will grow at a CAGR of 9.2% during the forecast period. The market has witnessed steady growth in the past few years and development in technology with the introduction of highly sensitive, robust, and reliable systems in the market. The market is fueled by rising demand for qPCR and dPCR in genetic and molecular testing, increasing private investment and funds, and increasing demand for biomarker-based tests.
 
 The market continues to grow and is one of the most widely used technology for the quantification of nucleic acid. The advanced technology has made the device simple, fast, and accurate. Vendors are focusing towards new product launches and targeting towards end-user’s perspective. The majority of the revenue is generated from the leading players in the market with dominating sales of Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen N.V., Abbott Laboratories, Danaher Corporation and F. Hoffmann-La Roche Ltd.
 According to Infoholic Research analysis, North America accounted for the largest share of the global qPCR and dPCR market in 2018. The increased usage of PCR in proteomics & genomics, advanced technologies such as qPCR and PCR-based laboratory developed tests for rare genetic diseases, cancers, and infectious diseases are driving the market in North America. The Asia Pacific region is expected to witness the fastest growth rate due to large patient pool and rising healthcare expenditure.
 
 By Product Type:
 • Instruments
 • Reagents and Consumables
 • Software and Services
 In 2018, the reagents and consumables segment occupied the largest share due to its advanced features and specialty-based operations. Many companies are focusing on providing even software services. In March 2017, ThermoFisher Scientific acquired Core Informatics, a provider of cloud-based platform supporting scientific data management.
 By Applications:
 • Clinical Diagnostics
 • Biomedical Research
 • Others
 In 2018, the biomedical research accounted the maximum share followed by the clinical diagnostics. The successful completion of Human genome project has driven the growth of qPCR and dPCR market.
 By Technology Type:
 • Qualitative PCR
 • Digital PCR
 qPCR has become the standard method for quantification of gene expression. Its high sensitivity, large dynamic range, and accuracy has led to the development of numerous applications with an increasing number of samples to be analyzed.
 By End Users:
 • Hospitals and Laboratories
 • Pharmaceutical Companies
 • Academics
 • Others
 In 2018, academics segment gained the highest market share for qPCR and dPCR market due to increased use of technology in the field of research.
 By Regions:
 • North America
 • Europe
 • APAC
 • ROW
 
 The market is dominated by North America, followed by Europe and Asia Pacific. The major share of the North America market is from the US due to the quick adoption of new and advanced technologies.
 qPCR and dPCR Market Research Competitive Analysis – The PCR is a matured technology, innovation in the instruments, reagents, and software is essential to maintain their market position. However, this doesn’t signify lack of improvement in both instruments and reagents. Superior sensitivity, improved multiplexing, better cDNA synthesis, and greater projectivity are the major features looked upon by the end-users of the market.
 
 Merger and acquisition have been major strategy followed by key players in the market to maintain their leadership in the market. In 2016, Thermo Fisher Scientific deployed around $5.5 billion on acquisitions. This is expected to increase the offerings and strategic positioning of the company. The company increased its Life Sciences Solutions business by acquiring Affymetrix. In early 2017, Bio-Rad Laboratories, leader in digital PCR acquired RainDance Technologies, the fastest growing company in dPCR and liquid biopsy markets.
 
 Key vendors:
 • Thermo Fisher Scientific
 • Bio-Rad Laboratories
 • Danaher Corp.
 • Agilent Technologies, Inc.
 • Qiagen N.V.
 • F. Hoffmann-La Roche
 • Abbott Laboratories
 • Promega Corp.
 • Eppendorf AG
 • BioMerieux S.A.
 • Merck KGaA
 
 Key competitive facts –
 • The market is highly competitive with all the players competing to gain market shares. Intense competition, rapid advancements in technology, and the prices are key factors that confront the market.
 • The requirement of high investment for the installation of the qPCR and specially the dPCR instruments are hampering the growth of the market.
 Benefits – The report provides complete details about the usage and adoption rate of qPCR and dPCR market. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives towards the medical devices segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.
 Key Takeaways:
 • Understanding the potential market opportunity with precise market size and forecast data
 • Detailed market analysis focusing on the growth of qPCR and dPCR industry
 • Factors influencing the growth of qPCR and dPCR market
 • In-depth competitive analysis of dominant and pure play vendors
 • Prediction analysis of qPCR and dPCR industry in both developed and developing regions
 • Key insights related to major segments of the qPCR and dPCR market
 • Latest market trend analysis impacting the buying behavior of the consumers
  

Global qPCR and dPCR Market 2019–2025
[93 pages report] This market research report includes a detailed segmentation of the global qPCR and dPCR market – By Technology Type (qPCR and dPCR), By Product Type (Instruments, Reagents & Consumables, and Software & Services), By Application (Clinical Diagnostics, Biomedical Research, and Others), By End Users (Hospitals & Laboratories, Pharmaceutical Companies, Academics, and Others), By Region (North America, Europe, Asia Pacific, and Rest of the World).
Overview of the Global qPCR and dPCR Market Research
Infoholic’s market research report predicts that the global qPCR and dPCR market will grow at a CAGR of 9.2% during the forecast period. The market has witnessed steady growth in the past few years and development in technology with the introduction of highly sensitive, robust, and reliable systems in the market. The market is fueled by rising demand for qPCR and dPCR in genetic and molecular testing, increasing private investment and funds, and increasing demand for biomarker-based tests.


The market continues to grow and is one of the most widely used technology for the quantification of nucleic acid. The advanced technology has made the device simple, fast, and accurate. Vendors are focusing towards new product launches and targeting towards end-user’s perspective. The majority of the revenue is generated from the leading players in the market with dominating sales of Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen N.V., Abbott Laboratories, Danaher Corporation and F. Hoffmann-La Roche Ltd.
According to Infoholic Research analysis, North America accounted for the largest share of the global qPCR and dPCR market in 2018. The increased usage of PCR in proteomics & genomics, advanced technologies such as qPCR and PCR-based laboratory developed tests for rare genetic diseases, cancers, and infectious diseases are driving the market in North America. The Asia Pacific region is expected to witness the fastest growth rate due to large patient pool and rising healthcare expenditure.
By Product Type:
• Instruments
• Reagents and Consumables
• Software and Services
In 2018, the reagents and consumables segment occupied the largest share due to its advanced features and specialty-based operations. Many companies are focusing on providing even software services. In March 2017, ThermoFisher Scientific acquired Core Informatics, a provider of cloud-based platform supporting scientific data management.
By Applications:
• Clinical Diagnostics
• Biomedical Research
• Others
In 2018, the biomedical research accounted the maximum share followed by the clinical diagnostics. The successful completion of Human genome project has driven the growth of qPCR and dPCR market.
By Technology Type:
• Qualitative PCR
• Digital PCR
qPCR has become the standard method for quantification of gene expression. Its high sensitivity, large dynamic range, and accuracy has led to the development of numerous applications with an increasing number of samples to be analyzed.
By End Users:
• Hospitals and Laboratories
• Pharmaceutical Companies
• Academics
• Others
In 2018, academics segment gained the highest market share for qPCR and dPCR market due to increased use of technology in the field of research.
By Regions:
• North America
• Europe
• APAC
• ROW
The market is dominated by North America, followed by Europe and Asia Pacific. The major share of the North America market is from the US due to the quick adoption of new and advanced technologies.
qPCR and dPCR Market Research Competitive Analysis – The PCR is a matured technology, innovation in the instruments, reagents, and software is essential to maintain their market position. However, this doesn’t signify lack of improvement in both instruments and reagents. Superior sensitivity, improved multiplexing, better cDNA synthesis, and greater projectivity are the major features looked upon by the end-users of the market.
Merger and acquisition have been major strategy followed by key players in the market to maintain their leadership in the market. In 2016, Thermo Fisher Scientific deployed around $5.5 billion on acquisitions. This is expected to increase the offerings and strategic positioning of the company. The company increased its Life Sciences Solutions business by acquiring Affymetrix. In early 2017, Bio-Rad Laboratories, leader in digital PCR acquired RainDance Technologies, the fastest growing company in dPCR and liquid biopsy markets.
Key vendors:
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Danaher Corp.
• Agilent Technologies, Inc.
• Qiagen N.V.
• F. Hoffmann-La Roche
• Abbott Laboratories
• Promega Corp.
• Eppendorf AG
• BioMerieux S.A.
• Merck KGaA
Key competitive facts –
• The market is highly competitive with all the players competing to gain market shares. Intense competition, rapid advancements in technology, and the prices are key factors that confront the market.
• The requirement of high investment for the installation of the qPCR and specially the dPCR instruments are hampering the growth of the market.
Benefits – The report provides complete details about the usage and adoption rate of qPCR and dPCR market. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives towards the medical devices segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.
Key Takeaways:
• Understanding the potential market opportunity with precise market size and forecast data
• Detailed market analysis focusing on the growth of qPCR and dPCR industry
• Factors influencing the growth of qPCR and dPCR market
• In-depth competitive analysis of dominant and pure play vendors
• Prediction analysis of qPCR and dPCR industry in both developed and developing regions
• Key insights related to major segments of the qPCR and dPCR market
• Latest market trend analysis impacting the buying behavior of the consumers

Key Stakeholders –




List Of Tables



TABLE 1 GLOBAL QPCR AND DPCR MARKET REVENUE, BY PRODUCT TYPE, 2018–2025 ($MILLION) 31
TABLE 2 QPCR AND DPCR MARKET REVENUE, BY PRODUCT TYPE, 2018–2025 ($MILLION) 35
TABLE 3 GLOBAL QPCR AND DPCR MARKET REVENUE, BY PRODUCT TYPE, 2018–2025 ($MILLION) 46
TABLE 4 SUITABILITY OF DPCR AND QPCR FOR MAJOR APPLICATIONS 52
TABLE 5 OTHER PROMINENT VENDORS 53
TABLE 6 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS 55
TABLE 7 THERMO FISHER SCIENTIFIC: RECENT DEVELOPMENTS 56
TABLE 8 F. HOFFMANN-LA ROCHE LTD.: PRODUCT OFFERINGS 62
TABLE 9 F. HOFFMANN-LA ROCHE LTD.: RECENT DEVELOPMENTS 62
TABLE 10 ABBOTT LABORATORIES: PRODUCT OFFERINGS 67
TABLE 11 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 67
TABLE 12 QIAGEN N.V.: OFFERINGS 73
TABLE 13 QIAGEN N.V.: RECENT DEVELOPMENTS 74
TABLE 14 BIO-RAD LABORATORIES: OFFERINGS 79
TABLE 15 BIO-RAD LABORATORIES: RECENT DEVELOPMENTS 80
TABLE 16 AGILENT TECHNOLOGIES INC.: SNAPSHOT 85
TABLE 17 AGILENT TECHNOLOGIES INC.: RECENT DEVELOPMENTS 86
TABLE 18 PROMEGA CORP.: OVERVIEW 88
TABLE 19 PROMEGA CORP.: RECENT DEVELOPMENTS 88
TABLE 20 EPPENDORF AG: OVERVIEW 89
TABLE 21 EPPENDORF AG.: RECENT DEVELOPMENTS 89
TABLE 22 BIOMERIEUX S.A.: SNAPSHOT 90
TABLE 23 BIOMERIEUX S.A.: RECENT DEVELOPMENTS 90
TABLE 24 MERCK KGAA: OVERVIEW 92
TABLE 25 MERCK KGAA.: RECENT DEVELOPMENTS 92
TABLE 26 DANAHER CORP.: OVERVIEW 93
TABLE 27 DANAHER CORP.: RECENT DEVELOPMENTS 94

 


List Of Figures

Charts

CHART 1 RESEARCH METHODOLOGY OF GLOBAL QPCR AND DPCR MARKET 14
DIGITAL PCR 17
REAL-TIME PCR 17
CHART 2 GLOBAL QPCR AND DPCR MARKET REVENUE, 2018–2025 ($MILLION) 18
CHART 3 PORTERS 5 FORCES ON GLOBAL QPCR AND DPCR MARKET 22
CHART 5 GLOBAL QPCR AND DPCR MARKET SEGMENTATION 26
CHART 6 MARKET DYNAMICS – DRIVERS, RESTRAINTS & OPPORTUNITIES 26
CHART 7 DRO - IMPACT ANALYSIS OF GLOBAL QPCR AND DPCR MARKET 30
CHART 8 KEY STAKEHOLDERS OF GLOBAL QPCR AND DPCR MARKET 31
CHART 9 GLOBAL QPCR AND DPCR MARKET SEGMENT REVENUE BY TECHNOLOGY TYPE, 2018 VS 2025 ($MILLION) 32
CHART 10 DIGITAL PCR INSTRUMENT MARKET REVENUE, BY TYPES 2018–2025 ($MILLION) 34
CHART 11 REAL TIME/QUANTITATIVE PCR INSTRUMENT MARKET REVENUE, BY TYPES 2018–2025 ($MILLION) 35
CHART 12 QPCR AND DPCR MARKET SEGMENT REVENUE BY PRODUCT TYPE, 2018 VS 2025 ($ MILLION) 36
CHART 13 QPCR AND DPCR INSTRUMENT MARKET REVENUE, BY PRODUCT TYPES 2018–2025 ($MILLION) 37
CHART 14 QPCR AND DPCR REAGENTS AND CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE 2018-2025 ($MILLION) 39
CHART 15 QPCR AND DPCR SOFTWARE AND SERVICES MARKET REVENUE, BY PRODUCT TYPE 2018-2025 ($MILLION) 40
CHART 16 QPCR AND DPCR MARKET SEGMENT REVENUE BY APPLICATION TYPES, 2018 (%) 41
CHART 17 GLOBAL QPCR AND DPCR MARKET SEGMENT REVENUE BY END USERS, 2018 (%) 43
CHART 18 QPCR AND DPCR MARKET BY REGIONAL SEGMENTATION, 2018 VS 2025 ($MILLION) 46
CHART 19 QPCR AND DPCR MARKET REVENUE IN NORTH AMERICA, 2018–2025 ($MILLION) 47
CHART 20 QPCR AND DPCR MARKET REVENUE IN EUROPE, 2018–2025 ($MILLION) 49
CHART 21 QPCR AND DPCR MARKET REVENUE IN ASIA PACIFIC, 2018–2025 ($MILLION) 50
CHART 22 QPCR AND DPCR REVENUE IN REST OF THE WORLD, 2018–2025 ($MILLION) 51
CHART 23 THERMO FISHER SCIENTIFIC INC.: OVERVIEW SNAPSHOT 59
CHART 24 THERMO FISHER SCIENTIFIC INC.: BUSINESS UNITS 59
CHART 25 THERMO FISHER SCIENTIFIC INC.: GEOGRAPHIC REVENUE 60
CHART 26 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS 62
CHART 27 F. HOFFMANN-LA ROCHE LTD.: OVERVIEW SNAPSHOT 63
CHART 28 F. HOFFMANN-LA ROCHE LTD.: BUSINESS UNITS 64
CHART 29 F. HOFFMANN-LA ROCHE LTD.: GEOGRAPHIC REVENUE 65
CHART 30 F. HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS 66
CHART 31 ABBOTT LABORATORIES: OVERVIEW SNAPSHOT 70
CHART 32 ABBOTT LABORATORIES: BUSINESS UNITS 70
CHART 33 ABBOTT LABORATORIES: GEOGRAPHIC REVENUE 72
CHART 34 ABBOTT LABORATORIES: SWOT ANALYSIS 73
CHART 35 QIAGEN N.V.: OVERVIEW SNAPSHOT 77
CHART 36 QIAGEN N.V.: BUSINESS UNITS 77
CHART 37 QIAGEN N.V.: GEOGRAPHIC REVENUE 78
CHART 38 QIAGEN N.V.: SWOT ANALYSIS 79
CHART 39 BIO-RAD LABORATORIES: OVERVIEW SNAPSHOT 82
CHART 40 BIO-RAD LABORATORIES: BUSINESS UNITS 82
CHART 41 BIO-RAD LABORATORIES: GEOGRAPHIC REVENUE 83
CHART 42 BIO-RAD LABORATORIES: SWOT ANALYSIS 84


2021 United Therapeutics Strategic SWOT Analysis--Performance, Capabilities, Goals and Strategies in the Global Biotechnology Industry

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.The report provides significant competitor information, analysis and insight critical to the

USD 750 View Report

2021 Seattle Genetics Strategic SWOT Analysis--Performance, Capabilities, Goals and Strategies in the Global Biotechnology Industry

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.The report provides significant competitor information, analysis and insight critical to the

USD 750 View Report

Global Qpcr Instrumentation Market Report 2019, Competitive Landscape, Trends and Opportunities

The Qpcr Instrumentation market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach

USD 2950 View Report

Asia Pacific Real Time Pcr Qpcr And Digital Pcr Dpcr Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Asia Pacific Real Time Pcr Qpcr And Digital Pcr Dpcr market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected

USD 3000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available